Free Trial

Shuttle Pharmaceuticals (SHPH) Competitors

Shuttle Pharmaceuticals logo
$0.39 -0.01 (-1.49%)
Closing price 03/28/2025 04:00 PM Eastern
Extended Trading
$0.38 -0.01 (-3.60%)
As of 03/28/2025 07:50 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

SHPH vs. ONCO, KLTO, CYCN, AYTU, UPC, BTAI, NKGN, HOTH, BFRI, and OMGA

Should you be buying Shuttle Pharmaceuticals stock or one of its competitors? The main competitors of Shuttle Pharmaceuticals include Onconetix (ONCO), Klotho Neurosciences (KLTO), Cyclerion Therapeutics (CYCN), Aytu BioPharma (AYTU), Universe Pharmaceuticals (UPC), BioXcel Therapeutics (BTAI), NKGen Biotech (NKGN), Hoth Therapeutics (HOTH), Biofrontera (BFRI), and Omega Therapeutics (OMGA). These companies are all part of the "pharmaceutical products" industry.

Shuttle Pharmaceuticals vs.

Onconetix (NASDAQ:ONCO) and Shuttle Pharmaceuticals (NASDAQ:SHPH) are both small-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their dividends, analyst recommendations, valuation, profitability, earnings, media sentiment, institutional ownership, community ranking and risk.

In the previous week, Onconetix had 3 more articles in the media than Shuttle Pharmaceuticals. MarketBeat recorded 4 mentions for Onconetix and 1 mentions for Shuttle Pharmaceuticals. Shuttle Pharmaceuticals' average media sentiment score of 1.87 beat Onconetix's score of 0.27 indicating that Shuttle Pharmaceuticals is being referred to more favorably in the news media.

Company Overall Sentiment
Onconetix Neutral
Shuttle Pharmaceuticals Very Positive

Onconetix has a beta of 3.27, suggesting that its share price is 227% more volatile than the S&P 500. Comparatively, Shuttle Pharmaceuticals has a beta of -1.63, suggesting that its share price is 263% less volatile than the S&P 500.

Shuttle Pharmaceuticals has lower revenue, but higher earnings than Onconetix.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Onconetix$1.87M3.16-$37.41MN/AN/A
Shuttle PharmaceuticalsN/AN/A-$6.59M-$4.15-0.09

Shuttle Pharmaceuticals has a net margin of 0.00% compared to Onconetix's net margin of -2,758.89%. Onconetix's return on equity of 0.00% beat Shuttle Pharmaceuticals' return on equity.

Company Net Margins Return on Equity Return on Assets
Onconetix-2,758.89% N/A -48.09%
Shuttle Pharmaceuticals N/A -583.02%-258.92%

23.9% of Onconetix shares are held by institutional investors. Comparatively, 4.6% of Shuttle Pharmaceuticals shares are held by institutional investors. 11.4% of Onconetix shares are held by company insiders. Comparatively, 39.6% of Shuttle Pharmaceuticals shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

Onconetix and Shuttle Pharmaceuticals both received 0 outperform votes by MarketBeat users.

CompanyUnderperformOutperform
OnconetixN/AN/A
Shuttle PharmaceuticalsN/AN/A

Summary

Onconetix beats Shuttle Pharmaceuticals on 6 of the 10 factors compared between the two stocks.

Remove Ads
Get Shuttle Pharmaceuticals News Delivered to You Automatically

Sign up to receive the latest news and ratings for SHPH and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

SHPH vs. The Competition

MetricShuttle PharmaceuticalsPharmaceutical IndustryMedical SectorNASDAQ Exchange
Market Cap$2.43M$6.90B$5.63B$7.84B
Dividend YieldN/A2.77%5.33%4.01%
P/E Ratio-0.097.2623.6018.74
Price / SalesN/A218.62388.2390.77
Price / CashN/A65.6738.1734.64
Price / Book0.196.386.894.23
Net Income-$6.59M$142.34M$3.20B$247.47M
7 Day Performance-7.64%-5.15%-3.06%-2.29%
1 Month Performance-36.10%-7.55%1.52%-5.81%
1 Year PerformanceN/A-11.06%9.37%-0.96%

Shuttle Pharmaceuticals Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
SHPH
Shuttle Pharmaceuticals
1.9672 of 5 stars
$0.39
-1.5%
N/AN/A$2.43MN/A-0.095Positive News
Gap Down
ONCO
Onconetix
0.5741 of 5 stars
$0.12
-6.4%
N/A-98.5%$7.73M$1.87M0.0012Short Interest ↑
Positive News
Gap Down
High Trading Volume
KLTO
Klotho Neurosciences
N/A$0.28
-3.2%
N/AN/A$7.68MN/A0.00N/AUpcoming Earnings
Positive News
Gap Down
CYCN
Cyclerion Therapeutics
2.3089 of 5 stars
$2.82
+2.5%
N/A-19.7%$7.64M$2M-2.3130Short Interest ↓
Gap Up
AYTU
Aytu BioPharma
2.0255 of 5 stars
$1.23
-0.8%
N/A-60.2%$7.59M$77.23M-0.85160Positive News
UPC
Universe Pharmaceuticals
N/A$4.39
+24.6%
N/A-99.6%$7.53M$26.73M0.00220Positive News
Gap Down
High Trading Volume
BTAI
BioXcel Therapeutics
4.6611 of 5 stars
$2.29
-1.7%
$42.60
+1,760.3%
-95.3%$7.47M$2.28M-0.0790Earnings Report
Short Interest ↓
News Coverage
Gap Down
NKGN
NKGen Biotech
N/A$0.17
+6.4%
N/A-91.4%$7.42M$80,000.00-0.03N/A
HOTH
Hoth Therapeutics
2.9367 of 5 stars
$1.07
-0.9%
$4.00
+273.8%
-32.2%$7.39MN/A-0.814Earnings Report
Short Interest ↑
BFRI
Biofrontera
2.2657 of 5 stars
$0.90
+4.8%
$7.00
+676.7%
-47.2%$6.98M$35.36M-0.4070Short Interest ↑
OMGA
Omega Therapeutics
1.9274 of 5 stars
$0.13
-21.8%
$9.20
+7,260.0%
-96.6%$6.92M$8.10M-0.09120Gap Up
Remove Ads

Related Companies and Tools


This page (NASDAQ:SHPH) was last updated on 3/30/2025 by MarketBeat.com Staff
From Our Partners